Stay updated with breaking news from Sofinnova Partners. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Funds to Support Completion of Clinical Program Through Commercialization of Novel Device Designed to Prevent Amputations in Patients with Chronic Limb-Threatening Ischemia LimFlow SA, a pioneer
/PRNewswire/ -- Asceneuron SA, a clinical stage company dedicated to targeting the root causes of neurodegenerative diseases, today announces the publication...
Mission Therapeutics ("Mission"), a drug discovery and development company focused on protein homeostasis by selectively inhibiting deubiquitylating enzymes (DUBs), today announced it has been granted
MILAN, ITALY / ACCESSWIRE / March 31, 2022 / AAVantgarde Bio, a Milan-based biotechnology start-up that is developing gene therapies for inherited retinal disorders based on Adeno-Associated Viral (AAV)
Sofinnova Partners is a leading European venture capital firm in life sciences, specializing in healthcare and sustainability.